Microsoft Word haluk tezw 1

41 

 

36.

 

Karagenc T, Bilgic HB, Hosgor M, Aysul N, Aypak S ve Eren H. Aydın yöresi 

sığırlarında RLB tekniği kullanılarak  Theileria,  Babesia,  Anaplasma,  Ehrlichia 

türlerinin belirlenmesi. 14. Ulusal Parazitoloji Kongresi.  İzmir, 2005.   

37.

 

Kostman JR. Laboratory diagnosis of rickettsial diseases. Clin Dermatol 1996;14:301-6. 

38.

 

Gürcan Ş. Ehrlichia. XXXI. Türk Mikrobiyoloji Kongresi Özet Kitabı. Aydın, 2004.  

39.

 

Fenollar F and Raoult D. Molecular genetic methods for the diagnosis of fastidious 

microorganisms. APMIS 2004;112:785-807. 

40.

 

Anaplasmataceae. 2008. 

http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=942

  

41.

 

Inokuma H, Brouqui P, Drancourt M and Raoult D. Citrate synthase gene sequence: a 

new tool for phylogenetic analysis and identification of Ehrlichia. J Clin Microbiol 

2001;39:3031-9. 

42.

 

Lee KN, Padmalayam I, Baumstark B, Baker SL and Massung RF. Characterization of 

the ftsZ gene from Ehrlichia chaffeensis, Anaplasma phagocytophilum, and Rickettsia 

rickettsii, and use as a differential PCR target. DNA Cell Biol 2003;22:179-86. 

43.

 

Massung RF, Lee K, Mauel M and Gusa A. Characterization of the rRNA genes of 

Ehrlichia chaffeensis and Anaplasma phagocytophila. DNA Cell Biol 2002;21:587-96. 

44.

 

Taillardat-Bisch AV, Raoult D and Drancourt M. RNA polymerase beta-subunit-based 

phylogeny of Ehrlichia spp., Anaplasma spp., Neorickettsia spp. and Wolbachia 

pipientis. Int J Syst Evol Microbiol 2003;53:455-8. 

45.

 

Olano J and Aguero-Rosenfeld ME. Ehrlichia, Anaplasma, and related intracellular 

Bacteria.  In: Murray P, Baron EJ, Jorgensen JH, Landry ME and Pfaller MA (Eds). 

Manual of Clinical Microbiology. 9

th

 ed. Washington DC: ASM Press;2007. p.1046-61. 

   

46.

 

Stuen S, Van DP, Bergstrom IK and Schouls LM. Identification of Anaplasma 

phagocytophila (formerly Ehrlichia phagocytophila) variants in blood from sheep in 

Norway. J Clin Microbiol 2002;40:3192-7. 

47.

 

Massung RF, Mauel MJ, Owens JH, Allan N, Courtney JW, Stafford KC et al. Genetic 

variants of Ehrlichia phagocytophila, Rhode Island and Connecticut. Emerg Infect Dis 

2002;8:467-72. 

48.

 

Brouqui P, Sanogo YO, Caruso G, Merola F and Raoult D. Candidatus Ehrlichia 

walkerii: a new Ehrlichia detected in Ixodes ricinus tick collected from asymptomatic 

humans in Northern Italy. Ann N Y Acad Sci 2003;990:134-40. 

49.

 

Blouin EF and Kocan KM. Morphology and development of Anaplasma marginale 

(Rickettsiales: Anaplasmataceae) in cultured Ixodes scapularis (Acari: Ixodidae) cells. J 

Med Entomol 1998;35:788-97. 

50.

 

Popov VL, Chen SM, Feng HM and Walker DH. Ultrastructural variation of cultured 

Ehrlichia chaffeensis. J Med Microbiol 1995;43:411-21. 

---

42 

 

51.

 

Brouqui P, Birg ML and Raoult D. Cytopathic effect, plaque formation, and lysis of 

Ehrlichia chaffeensis grown on continuous cell lines. Infect Immun 1994;62:405-11. 

52.

 

Ohashi N, Zhi N, Lin Q and Rikihisa Y. Characterization and transcriptional analysis of 

gene clusters for a type IV secretion machinery in human granulocytic and monocytic 

ehrlichiosis agents. Infect Immun 2002;70:2128-38. 

53.

 

Fishbein DB, Dawson JE and Robinson LE. Human ehrlichiosis in the United States, 

1985 to 1990. Ann Intern Med 1994;120:736-43. 

54.

 

Paddock CD and Childs JE. Ehrlichia chaffeensis: a prototypical emerging pathogen. 

Clin Microbiol Rev 2003;16:37-64. 

55.

 

Standaert SM, Yu T, Scott MA, Childs JE, Paddock CD, Nicholson WL et al. Primary 

isolation of Ehrlichia chaffeensis from patients with febrile illnesses: clinical and 

molecular characteristics. J Infect Dis 2000;181:1082-8. 

56.

 

Schutze GE and Jacobs RF. Human monocytic ehrlichiosis in children. Pediatrics 

1997;100:e10. 

57.

 

Olano JP and Walker DH. Human ehrlichioses. Med Clin North Am 2002;86:375-92. 

58.

 

Safdar N, Love RB and Maki DG. Severe Ehrlichia chaffeensis infection in a lung 

transplant recipient: a review of ehrlichiosis in the immunocompromised patient. Emerg 

Infect Dis 2002;8:320-3. 

59.

 

Paddock CD, Suchard DP, Grumbach KL, Hadley WK, Kerschmann RL, Abbey NW et 

al. Brief report: fatal seronegative ehrlichiosis in a patient with HIV infection. N Engl J 

Med 1993;329:1164-7. 

60.

 

Paddock CD, Sumner JW, Shore GM, Bartley DC, Elie RC, McQuade JG et al. 

Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal 

ehrlichiosis. J Clin Microbiol 1997;35:2496-502. 

61.

 

Marty AM, Dumler JS, Imes G, Brusman HP, Smrkovski LL and Frisman DM. 

Ehrlichiosis mimicking thrombotic thrombocytopenic purpura. Case report and 

pathological correlation. Hum Pathol 1995;26:920-5. 

62.

 

Fichtenbaum CJ, Peterson LR and Weil GJ. Ehrlichiosis presenting as a life-threatening 

illness with features of the toxic shock syndrome. Am J Med 1993;95:351-7. 

63.

 

Table 2. Summary of provisional cases of selected notifiable diseases. 2005.  

http://www.cdc.gov/mmwr/preview/mmwrhtml

  

64.

 

Olano JP, Masters E, Hogrefe W and Walker DH. Human monocytotropic ehrlichiosis, 

Missouri. Emerg Infect Dis 2003;9:1579-86. 

65.

 

Brouqui P, Le CC, Kelly PJ, Laurens R, Tounkara A, Sawadogo S et al. Serologic 

evidence for human ehrlichiosis in Africa. Eur J Epidemiol 1994;10:695-8. 

---